Seminars in Nephrology
Volume 25, Issue 1 , Pages 3-8 , January 2005

Uric acid, evolution and primitive cultures

  • Richard J. Johnson

      Affiliations

    • Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, FL
    • Corresponding Author InformationAddress reprint requests to Richard J. Johnson, MD, Division of Nephrology, Hypertension, and Transplantation, PO Box 100024, University of Florida, Gainesville, FL 32610
  • ,
  • Srinivas Titte

      Affiliations

    • Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, FL
  • ,
  • J. Robert Cade

      Affiliations

    • Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, FL
  • ,
  • Bruce A. Rideout

      Affiliations

    • Center for Reproduction of Endangered Species, Zoological Society of San Diego, San Diego CA
  • ,
  • William J. Oliver

      Affiliations

    • Department of Pediatrics, University of Michigan, Ann Arbor, MI

References 

  1. American Heart Association: Cardiovascular disease statistics. Available at: www.americanheart.org, 2002
  2. Forrester T , Cooper RS , Weatherall D . Emergence of Western diseases in the tropical world (The experience with chronic cardiovascular diseases) . Br Med Bull . 1998;54:463–473
  3. Singh RB , Suh IL , Singh VP , et al.   Hypertension and stroke in Asia (Prevalence, control and strategies in developing countries for prevention) . J Hum Hypertens . 2000;14:749–763
  4. Seedat YK . Hypertension in developing nations in sub-Saharan Africa . J Hum Hypertens . 2000;14:739–747
  5. Danzinger RS . Hypertension in an anthropological and evolutionary paradigm . Hypertension . 2001;38:19–22
  6. Oda M , Satta Y , Takenaka O , et al.   Loss of urate oxidase activity in hominoids and its evolutionary implications . Mol Biol Evol . 2002;19:640–653
  7. Friedman TB , Polanco GE , Appold JC , et al.   On the loss of uricolytic activity during primate evolution—I. Silencing of urate oxidase in a hominoid ancestor . Comp Biochem Physiol . 1985;81B:653–659
  8. Bradley A , Caskey CT . Hyperuricemia and urate nephropathy in urate oxidase deficient mice . Proc Natl Acad Sci U S A . 1994;91:742–746
  9. Xu P , LaVallee P , Hoidal JR . Repressed expression of the human xanthine oxidoreductase gene . J Biol Chem . 2000;275:5918–5926
  10. Orowan E . The origin of man . Nature . 1955;175:683–684
  11. Ames BN , Cathcart R , Schwiers E , et al.   Uric acid provides an antioxidant defense in humans against oxidant- and radical-causing aging and cancer (A hypothesis) . Proc Natl Acad Sci U S A . 1981;78:6853–6862
  12. Nieto FJ , Iribarren C , Gross MD , et al.   Uric acid and serum antioxidant capacity (A reaction to atherosclerosis?) . Atherosclerosis . 2000;148:131–139
  13. Spitsin SV , Scott GS , Mikheeva T , et al.   Comparison of uric acid and ascorbic acid in protection against EAE . Free Radic Biol Med . 2002;33:1363–1371
  14. Nishikimi M , Fukuyama R , Minoshima S , et al.   Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man . J Biol Chem . 1994;269:13685–13688
  15. Pauling L . Evolution and the need for ascorbic acid . Proc Natl Acad Sci U S A . 1970;67:1643–1648
  16. Lopez-Torres M , Pererz-Campo R , Rojas C . Maximum life span in vertebrates (Relationship with liver anti-oxidant enzymes, glutathione system, ascorbate, urate, sensitivity to peroxidation, true malondialydehyde, in vivo H2O2, and basal and maximum aerobic capacity) . Mech Ageing Dev . 1993;70:177–199
  17. Johnson RJ , Kang DH , Feig D , et al.   Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? . Hypertension . 2003;41:1183–1190
  18. Watanabe S , Kang DH , Feng L , et al.   Uric acid, hominoid evolution and the pathogenesis of salt-sensitivity . Hypertension . 2002;40:355–360
  19. Mazzali M , Hughes J , Kim YG , et al.   Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism . Hypertension . 2001;38:1101–1106
  20. Mazzali M , Kanellis J , Han L , et al.   Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism . Am J Physiol . 2002;282:F991–F997
  21. Kanellis J , Watanabe S , Li JH , et al.   Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2 . Hypertension . 2003;41:1287–1293
  22. Feig DI , Johnson RJ . Hyperuricemia in childhood essential hypertension . Hypertension . 2003;42:247–252
  23. Feig DI , Nakagawa T , Karumanchi SA , et al.   Uric acid, nephron number, and the pathogenesis of essential hypertension . Kidney Int . 2004;66:281–287
  24. Johnson RJ , Rideout BA . Uric acid and diet (Insights into the epidemic of cardiovascular disease) . N Engl J Med . 2004;350:1071–1074
  25. Choi HK , Atkinson K , Karlson EW , et al.   Purine-rich foods, dairy intake, and protein intake, and risk of gout in men . N Engl J Med . 2004;350:1093–1103
  26. Mahomed FA . On chronic Bright’s disease, and its essential symptoms . Lancet . 1879;I:399–401
  27. Nriagu JO . Saturnine gout among Roman aristocrats. Did lead poisoning contribute to the fall of the Empire . N Engl J Med . 1983;308:660–663
  28. Haig A . On uric acid and arterial tension . Br Med J . 1889;1:288–291
  29. Huchard H . Arteriolosclerosis (Including its cardiac form) . JAMA . 1909;53:1129
  30. Huchard H . Allgemeine Betrachtungen űber die Arteriosklerose . Klin Med Berlin . 1909;5:1318–1321
  31. Donnison CP . Blood pressure in the African native . Lancet . 1929;1:6–7
  32. Williams AW . Blood pressure of Africans . East Afr Med J . 1941;18:109–117
  33. Hudson EH , Young AL . Medical and surgical practice on the Euphrates River. An analysis of two thousand consecutive cases at Deir-Ez-Zor, Syria . Am J Trop Med Hyg . 1931;11:297–310
  34. McCay D . Physiological and pathological observations on Wright’s method of testing the blood and urine . Lancet . 1907;1:1483–1487
  35. Cadbury WW . Blood pressure of normal Cantonese Students . Arch Intern Med . 1922;30:362–377
  36. Lowenstein FW . Some epidemiological aspects of blood pressure and its relationship to diet and constitution with particular consideration of the Chinese . Am Heart J . 1954;47:874–885
  37. Saunders GM . Blood pressure in Yucatecans . Am J Med Sci . 1933;185:843–851
  38. Kean BH . The blood pressure of the Cuna Indians . Am J Trop Med Hyg . 1944;24:341–343
  39. Shattuck GC . The possible significance of low blood pressures observed in Guatemalans and in Yucatecans . Am J Trop Med Hyg . 1937;17:513–537
  40. Lowenstein FW . Blood-pressure in relation to age and sex in the tropics and subtropics . Lancet . 1961;1:389–392
  41. Murrill RI . A blood pressure study of natives of Ponape Island, Eastern Carolines . Hum Biol . 1948;20:47–57
  42. Nye LJJ . Blood pressure in the Australian Aborigine with consideration of possible aetiologic factors in hyperpiesia and its relation to civilization . Med J Aust . 1937;2:1000–1001
  43. Fleming HC . Medical observations of the Zuni Indians . Contributions from the Museum of the American Indian . New York City: Heinze Foundation; 1924;
  44. Adams JM . Some racial differences in blood pressure and morbidity in a group of white and colored workers . Am J Med Sci . 1930;184:342–350
  45. Saunders GM , Bancroft H . Blood pressure studies on negro and white men and women living in the Virgin Islands of the United States . Am Heart J . 1942;23:410–423
  46. Perlman L , Bernstein A , Maslow WC , et al.   Gout in a Negro woman (Report of a case) . JAMA . 1953;151:726–728
  47. Nathan LA , Kubota CK , Turnbull GC . Relative incidence of gout in negro and white males at Cook County Hospital 1944–1952 . J Lab Clin Med . 1953;42:927
  48. Hochberg MC , Thomas J , Thomas DJ , et al.   Racial differences in the incidence of gout . Arthritis Rheum . 1995;38:628–632
  49. Cassim B , Mody GM , Deenadayalu VK , et al.   Gout in black South Africans (A clinical and genetic study) . Ann Rheum Dis . 1994;53:759–762
  50. Beighton P , Solomon L , Soskolne CL , et al.   Serum uric acid concentrations in an urbanized South African Negro population . Ann Rheum Dis . 1974;33:442–445
  51. Beighton P , Daynes G , Soskolne CL . Serum uric acid concentrations in a Xhosa community in the Transkei of Southern Africa . Ann Rheum Dis . 1976;35:77–80
  52. Wright-St Clair RE . Early accounts of Maori diet and health . N Z Med J . 1969;70:327–331
  53. Lennane GAQ , Rose BS , Isdale IC . Gout in the Maori . Ann Rheum Dis . 1960;19:120–125
  54. Rose BS . Gout in the Maoris . Semin Arthritis Rheum . 1975;5:121–145
  55. Hoy W , Kelly A , Jacups S , et al.   Stemming the tide (Reducing cardiovascular disease and renal failure in Australian Aborigines) . Aust N Z J Med . 1999;29:480–483
  56. Chin G , Segasothy M . Gouty arthritis in Australian Aborigines . Aust N Z J Med . 2000;30:639–640
  57. Decker JL , Lane JJ . Gouty arthritis in Filipinos . N Engl J Med . 1959;261:805–806
  58. Decker JL , Lane JJ , Reynolds WE . Hyperuricemia in a male Filipino population . Arthritis Rheum . 1962;5:144–155
  59. Healey LA , Skeith MD , Decker JL , et al.   Hyperuricemia in Filipinos (Interaction of heredity and environment) . Am J Hum Genet . 1967;19:81–85
  60. Kagan A , Harriss BR , Winkelstein W , et al.   Epidemiologic studies on coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California (Demographic, physical, dietary and biochemical characteristics) . J Chron Dis . 1974;27:345–364
  61. Saile F . Ûber den Einfluβ der vegetarischen Ernährung auf den Blutdruck . Med Klin . 1930;25:929–931
  62. Oliver WJ , Cohen EL , Neel JV . Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a “No-salt” culture . Circulation . 1975;52:146–151
  63. Prior IAM , Evans JG , Harvey HPB , et al.   Sodium intake and blood pressure in two Polynesian populations . N Engl J Med . 1968;279:515–520
  64. Elliot P , Stamler J , Nichols R , et al.   Intersalt revisited (Further analyses of 24 hour sodium excretion and blood pressure within and across populations) . Br Med J . 1996;312:1249–1253
  65. Oliver WJ . Primitive Peoples Without Salt (A Perspective for Industrialized Societies) . Michigan: Ann Arbor; 1998;
  66. Wilson WK , Sica DA , Miller SB . Effect of potassium on blood pressure in salt-sensitive and salt-resistant Black adolescents . Hypertension . 1999;34:181–186
  67. Suga S , Phillips MI , Ray PE , et al.   Hypokalemia induces renal injury and alterations in intrarenal vasoactive mediators that favor salt-sensitivity . Am J Physiol . 2001;281:F620–F629
  68. Tuomilehto J , Zimmet P , Wolf E , et al.   Plasma uric acid level and its association with diabetes mellitus and some biological parameters in a biracial population of Fiji . Am J Epidemiol . 1988;127:321–336
  69. Hollenberg NK , Martinez G , McCullough M , et al.   Aging, acculturation, salt intake, and hypertension in the Kuna of Panama . Hypertension . 1997;29:171–176
  70. Chamberlain WP . A study of the systolic blood pressure and the pulse rate of healthy adult males in the Philippines . Philippine J Sci . 1911;6:467–482
  71. Sun Z , Zang A , Cade JR . Renal responses to chronic cold exposure . Can J Physiol Pharmacol . 2003;81:22–27
  72. Li YC , Kong J , Wei M , et al.   1,25 dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system . J Clin Invest . 2002;110:229–238
  73. Takahashi S , Yamamoto T , Moriwaki Y , et al.   Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout . Adv Exp Med Biol . 1998;431:57–60
  74. Schlotthauer CV , Bollman JL . Experimental gout in turkeys . Proc Staff Med Mayo Clinic . 1934;9:560–561
  75. Laurence DR , Bennett PN . Clinical Pharmacology . In: Drugs Used in Arterial Hypertension and Angina Pectoris . ed 6. Edinburgh: Churchill Livingstone; 1987;p. 505
  76. Prior IAM , Rose BS , Harvey HPB , et al.   Hyperuricemia, gout, and diabetic abnormality in Polynesian people . Lancet . 1966;1:333–338
  77. Fang J , Alderman MH . Serum uric acid and cardiovascular mortality. The NHANES I epidemiologic follow-up study, 1971–1992 . JAMA . 2000;283:2404–2410

 Supported by National Institutes of Health grants HL-68607 and DK-52121.

PII: S0270-9295(04)00145-7

doi: 10.1016/j.semnephrol.2004.09.002

Seminars in Nephrology
Volume 25, Issue 1 , Pages 3-8 , January 2005